Related Experiment Videos

Depression in older age is a risk factor for first ischemic cardiac events

Marijke A Bremmer1, Witte J G Hoogendijk, Dorly J H Deeg

  • 1Department of Psychiatry, VU University Medical Center, Amsterdam. ma.bremmer@vumc.nl

Insights

Major depression in older adults significantly increases the risk of cardiac events, primarily ischemic heart disease. This finding highlights the critical link between late-life depression and cardiovascular health outcomes.

Area of Science:

  • Cardiology
  • Psychiatry
  • Gerontology

Background:

  • Depressive disorders are linked to increased cardiac disease and mortality, but the mechanism remains unclear.
  • The study investigates if subclinical atherosclerosis mediates the association between late-life depression and ischemic heart disease.

Purpose of the Study:

  • To determine if major depression in older adults predicts future cardiac events.
  • To ascertain if the increased risk is specifically confined to ischemic heart diseases.

Main Methods:

  • Longitudinal Aging Study Amsterdam cohort (2,403 participants, aged 55+) without prior cardiac disease.
  • Assessed onset of cardiac disease or death over a mean follow-up of 7.2 years.
  • Differentiated between ischemic heart diseases and other cardiac conditions; Major Depressive Disorder (MDD) diagnosed via DSM-III criteria.

Main Results:

  • Major Depressive Disorder (MDD) conferred a 2.09-fold increased risk for any cardiac event.
  • The risk for ischemic heart events specifically increased by 3.00-fold in individuals with MDD.
  • Subthreshold depression did not significantly elevate the risk of future cardiac events.

Conclusions:

  • Major depression in older adults is a significant predictor of first cardiac events.
  • The excess cardiac morbidity and mortality associated with major depression are attributable to ischemic heart diseases.
Abstract

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...